Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21831130 | 1.00 | DGKZ (0.72) | DGKZDGKA | |
| SCHEMBL30554449 | 0.94 | DGKZ (0.79) | DGKZDGKA | |
| SCHEMBL21830820 | 0.94 | DGKZ (0.79) | DGKZDGKA | |
| SCHEMBL25326700 | 0.94 | DGKZ (0.79) | DGKZDGKA | |
| SCHEMBL21831369 | 0.91 | DGKZ (0.74) | DGKZDGKA | |
| SCHEMBL30554264 | 0.91 | DGKZ (0.74) | DGKZDGKA | |
| SCHEMBL21831127 | 0.91 | DGKA (0.85) | DGKZDGKA | |
| SCHEMBL30554221 | 0.91 | DGKA (0.85) | DGKZDGKA | |
| SCHEMBL21830658 | 0.89 | DGKA (0.78) | DGKZDGKA | |
| SCHEMBL21831128 | 0.89 | DGKA (0.78) | DGKZDGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112654621-B | Substituted naphthyridinone compounds useful as T cell activators | 百时美施贵宝公司 | 2024-05-14 | — | — | CN | claimed |
| EP-3814348-B9 | SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS | BRISTOL MYERS SQUIBB CO (US) | 2023-11-01 | — | — | EP | claimed |
| EP-3814348-B1 | SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS | BRISTOL MYERS SQUIBB CO (US) | 2023-08-02 | — | — | EP | claimed |
| CN-112654621-B | Substituted naphthyridinone compounds useful as T cell activators | 百时美施贵宝公司 | 2024-05-14 | — | — | CN | disclosed |
| EP-3814348-B9 | SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS | BRISTOL MYERS SQUIBB CO (US) | 2023-11-01 | — | — | EP | disclosed |
| EP-3814348-B1 | SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS | BRISTOL MYERS SQUIBB CO (US) | 2023-08-02 | — | — | EP | disclosed |